Sponsor of the Day:
Jerkmate
https://www.law.com/newyorklawjournal/2026/04/01/magistrate-judge-proposes-sanctions-for-claims-filer-that-misled-merchants-on-56b-visa-mastercard-deal/?slreturn=20260409131928
Magistrate Judge Proposes Sanctions for Claims Filer that Misled Merchants on $5.6B Visa,...
magistrate judge5 6bproposessanctionsclaims
https://www.biospace.com/business/biogen-secures-running-start-in-kidney-disease-with-5-6b-apellis-buy
Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy - BioSpace
Mar 31, 2026 - In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will support the future launch of the...
kidney disease5 6bbiogensecuresapellis
https://www.casino.org/news/new-york-city-casinos-seen-posting-up-to-5-6b-in-annual-revenue/
New York City Casinos Seen Posting up to $5.6B in Annual Revenue
Mar 25, 2026 - New York City Casinos Seen Posting up to $5.6B in Annual Revenue.
new york city5 6bannual revenuecasinosseen
https://www.audible.com/podcast/Creatively-outmarketing-industry-giants-to-a-56B-valuation-Jon-Stona-Airwallex/B0DQPYFT3D
Creatively outmarketing industry giants to a $5.6B valuation | Jon Stona (Airwallex) | Ahrefs...
How can you rise to unicorn status in an industry dominated by legacy players? Jon Stona, VP of Global Marketing at B2B global payments processor ...
industry giants5 6bcreativelyvaluationjon
https://www.biopharmadive.com/news/Biogen-kramer-cfo-deal-acquisition-apellis-early-assets-immunology-rare-neuroscience/816378/
Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets | BioPharma Dive
In an interview, Chief Financial Officer Robin Kramer said the combined cash flow from Biogen and Apellis will not only help debt leverage ratios but also free...
5 6bearly stagebiopharma divebiogenheels